Literature DB >> 20889884

Non-oral treatment with ivermectin for disseminated strongyloidiasis.

Dahlene N Fusco1, Jennifer A Downs, Michael J Satlin, Meera Pahuja, Liz Ramos, Philip S Barie, Lawrence Fleckenstein, Henry W Murray.   

Abstract

Critically ill patients with disseminated strongyloidiasis may not be candidates for oral treatment. We report four patients with disseminated strongyloidiasis, believed to be unable to absorb oral therapy, who were treated with ivermectin by rectal and/or subcutaneous administration. Obtaining subcutaneous ivermectin and dosing it appropriately is a challenge. These cases underscore the need for improved access to subcutaneous ivermectin and more pharmacological data to guide use of this treatment approach.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20889884      PMCID： PMC2946761          DOI： 10.4269/ajtmh.2010.10-0258

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  26 in total

Review 1.  Dysregulation of strongyloidiasis: a new hypothesis.

Authors:  R M Genta
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

Review 2.  Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis.

Authors:  Rafael Igual-Adell; Carlos Oltra-Alcaraz; Enrique Soler-Company; Pilar Sánchez-Sánchez; Josefa Matogo-Oyana; David Rodríguez-Calabuig
Journal:  Expert Opin Pharmacother       Date:  2004-12       Impact factor: 3.889

3.  Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.

Authors:  Jerome Pacanowski; Marie Dos Santos; Antoine Roux; Christine LE Maignan; Jacques Guillot; Veronique Lavarde; Muriel Cornet
Journal:  Am J Trop Med Hyg       Date:  2005-07       Impact factor: 2.345

4.  Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.

Authors:  Stephen A Turner; J Dick Maclean; Lawrence Fleckenstein; Christina Greenaway
Journal:  Am J Trop Med Hyg       Date:  2005-11       Impact factor: 2.345

5.  Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.

Authors:  Francisco M Marty; Colleen M Lowry; Martin Rodriguez; Danny A Milner; Walter S Pieciak; Anushua Sinha; Lawrence Fleckenstein; Lindsey R Baden
Journal:  Clin Infect Dis       Date:  2005-05-11       Impact factor: 9.079

6.  Fatal strongyloidiasis in patients receiving corticosteroids.

Authors:  T Cruz; G Reboucas; H Rocha
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

7.  A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children.

Authors:  H Marti; H J Haji; L Savioli; H M Chwaya; A F Mgeni; J S Ameir; C Hatz
Journal:  Am J Trop Med Hyg       Date:  1996-11       Impact factor: 2.345

8.  Evaluation of techniques for the diagnosis of Strongyloides stercoralis in human immunodeficiency virus (HIV) positive and HIV negative individuals in the city of Itajaí, Brazil.

Authors:  Jucelene Marchi Blatt; Geny Aparecida Cantos
Journal:  Braz J Infect Dis       Date:  2003-12       Impact factor: 1.949

9.  Ivermectin treatment of naturally acquired and experimentally induced Strongyloides stercoralis infections in dogs.

Authors:  L S Mansfield; G A Schad
Journal:  J Am Vet Med Assoc       Date:  1992-09-01       Impact factor: 1.936

10.  Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.

Authors:  H P Hauber; J Galle; P L Chiodini; J Rupp; R Birke; E Vollmer; P Zabel; C Lange
Journal:  Infection       Date:  2005-10       Impact factor: 3.553
View more
  11 in total

1.  Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.

Authors:  Isaac I Bogoch; Kamran Khan; Howard Abrams; Caroline Nott; Elizabeth Leung; Lawrence Fleckenstein; Jay S Keystone
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

2.  Imported strongyloidiasis: epidemiology, presentations, and treatment.

Authors:  Dora Buonfrate; Andrea Angheben; Federico Gobbi; Jose Muñoz; Ana Requena-Mendez; Eduardo Gotuzzo; Maria Alejandra Mena; Zeno Bisoffi
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

3.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

4.  Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.

Authors:  Carl Boodman; Yashpal S Chhonker; Daryl J Murry; Allison Mah; Jennifer Grant; Theodore Steiner; Michael Libman; Cesilia Nishi; Marthe Charles
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

Review 5.  Strongyloidiasis--an insight into its global prevalence and management.

Authors:  Santhosh Puthiyakunnon; Swapna Boddu; Yiji Li; Xiaohong Zhou; Chunmei Wang; Juan Li; Xiaoguang Chen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-14

6.  Treatment of disseminated Strongyloides spp. infection in an infant Sumatran orangutan (Pongo abelii).

Authors:  Laura M Kleinschmidt; Matthew E Kinney; Christopher S Hanley
Journal:  J Med Primatol       Date:  2018-03-01       Impact factor: 0.667

Review 7.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

8.  Strongyloides stercoralis Hyperinfection in an HIV-Infected Patient Successfully Treated with Subcutaneous Ivermectin.

Authors:  Paolo Antonio Grossi; Domenico Lombardi; Alessia Petrolo; Cristina Rovelli; Zaira Di Rosa; Giorgio Perriccioli; Agostino Rossi; Giulio Minoja; Francesco Scaglione; Daniela Dalla Gasperina
Journal:  Trop Med Infect Dis       Date:  2018-04-27

9.  Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population.

Authors:  Kristen Zeitler; Ripal Jariwala; Ricardo Restrepo-Jaramillo; Shyam Kapadia; Beata Casanas; Sally Alrabaa; Chakrapol Sriaroon
Journal:  BMJ Case Rep       Date:  2018-06-04

10.  Post-Renal Transplant Miliary Mottling: Not Always Tuberculosis.

Authors:  T Yashwanth Raj; R Vairakkani; T S Harshavardhan; N D Srinivasaprasad; V Dilli Rani; M Edwin Fernando
Journal:  Indian J Nephrol       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.